Effects of cytokines on the culture and differentiation of dendritic cells in vitro

Journal of Hematotherapy and Stem Cell Research

Volumn 10, Issue 1, 2001, Pages 43-51

  Syme, R ^a   Gluck S ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 3; INTERLEUKIN 4; STEM CELL FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

BIOLOGICAL THERAPY; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL MATURATION; DENDRITIC CELL; HUMAN; IMMUNOTHERAPY; IN VITRO STUDY; PRIORITY JOURNAL; REVIEW;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; HUMANS;

EID: 0035084969     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581601750098219     Document Type: Review

References (82)

1. Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo
2. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset
3. Human peripheral blood contains two distinct lineages of dendritic cells
4. CTL priming by CD8(+) and CD8(-) dendritic cells in vivo
5. Distinct signals control the hematopoiesis of lymphoid-related dendritic cells
6. A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma
7. Monoclonal antibody therapy in cancer
8. Therapy of metastatic breast cancer with humanized antibodies against the HER2 receptor protein
9. In vitro generation of human dendritic cells and cell therapy
10. Isolation, phenotype and allostimulatory activity of mouse liver dendritic cells
11. Isolation of epidermal Langerhans cells
12. Isolation and characterization of human tonsil dendritic cells
13. Long-term ex vivo maintenance and expansion of transplantable human hematopoietic stem cells
14. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α
15. Characterization and transfusion of in Vitro cultivated hematopoietic progenitor cells
16. Generation of dendritic cell in vitro from patients with breast cancer, and lymphoma and normal donors: Differences in steady state versus mobilized blood
17. A comparative study of the generation of dendritic cells from mobilized peripheral blood progenitor cells of patients undergoing high-dose chemotherapy
18. Human dendritic cells
19. Isolation of human blood dendritic cells by discontinuous nycodenz gradient centrifugation
20. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
21. Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium
22. The distinct surface of human blood dendritic cells, as observed after an improved isolation
23. Veiled accessory cells deduced from monocytes
24. Differentiation of human monocytes into CD14 negative accessory cells: Do dendritic cells derive from the monocytic lineage
25. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells
26. + hematopoietic progenitor cells of the bone marrow and peripheral blood
27. Proliferating dendritic cell progenitors in human blood
28. Expansion of immunostimulatory dendritic cells from peripheral blood of patients with cancer
29. + progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of melan-A/Mart-1(27-35)-specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursors
30. + peripheral blood progenitor cell and monocyte derived dendritic cells: A comparative analysis
31. Phenotypic and functional differences between human dendritic cells derived in vitro from hematopoietic progenitors and from monocyte/macrophages
32. + T cells
33. + hematopoietic progenitor cells
34. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
35. Identification of proliferating dendritic cell precursors in mouse blood
36. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augmented antigen presentation function
37. Uptake of bead-adsorbed versus soluble antigen by bone marrow derived dendritic cells triggers their activation and increases their antigen presentation capacity
38. + peripheral blood monocytes
39. CD1 and the expanding universe of T cell antigens
40. Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro
41. Antigen-specific cancer immunotherapy using a GM-CSF secreting allogenic tumor cell-based vaccine
42. Modulation of phenotypic and functional properties of human peripheral blood monocytes by IL-4
43. Differentiation of human dendritic cells from monocytes in vitro
44. Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application
45. Mechanisms of tumor necrosis factor-granulocyte-macrophage colony-stimulating factor-induced dendritic cell development
46. + progenitors
47. + blood dendritic cells
48. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells
49. The role of stem cell factor in mobilization of peripheral blood progenitor cells
50. + bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha
51. + bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor and TNF-α
52. Role of c-kit ligand in the expansion of human hematopoietic progenitor cells
53. Cytokines at the research-clinical interface: Potential applications
54. Biological effects and potential clinical applications of Flt3 ligand
55. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified
56. Intravenous injection of naked DNA encoding secreted flt3 ligand dramatically increases the number of dendritic cells and natural killer cells in vitro
57. + progenitor cells with flt3 ligand, c-kit ligand, GM-CSF, IL-4, and TNF-alpha are functional antigen presenting cells resembling mature monocyte-derived dendritic cells
58. + progenitor cells
59. + dendritic cell precursors differentiating from cord blood CD34+ progenitors
60. IL-13 supports differentiation of dendritic cells from circulating precursors in concert with GM-CSF
61. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages
62. IL-13 can substitute for IL-4 in the generation of dendritic cells for the induction of cytotoxic T lymphocytes and gene therapy
63. The role of IL-13 in the generation of dendritic cells in vitro
64. Interleukin-13 is involved in functional maturation of human peripheral blood monocyte-derived dendritic cells
65. IL-10 inhibits the primary allogeneic T cell response to human peripheral blood dendritic cells
66. B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is down-regulated by interferon-gamma or by interleukin-10
67. High level IL-12 production by murine dendritic cells: Upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10
68. Interleukin-10 increases mannose receptor expression and endocytic activity in monocyte-derived dendritic cells
69. Contrasting effects of TGF-beta and TNF-alpha on the development of dendritic cells from progenitors in mouse bone marrow
70. Developmental regulation by cytokines of bone marrow-derived dendritic cells and epidermal Langerhans cells
71. Regulation of GM-CSF-induced dendritic cell development by TGF-β1 and co-developing macrophages
72. Accelerated cell-cycling of hematopoietic progenitors by the flt3 ligand that is modulated by transforming growth factor-beta
73. Transforming growth factor betal, in the presence of granulocyte/macrophage colony-stimulating factor and interleukin 4, induces differentiation of human peripheral blood monocytes in to dendritic Langerhans cells
74. TGF-beta 1 prevents the noncognate maturation of human dendritic Langerhans cells
75. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Downregulation by cytokines and bacterial products
76. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability
77. Dendritic cells and the control of immunity
78. + dendritic cells
79. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily
80. Induction of IL-15 messenger RNA and protein in human blood-derived dendritic cells
81. + human blood dendritic cells for active tumor immunotherapy